Literature DB >> 12543379

Low chemical specificity of the nicotinic acetylcholine receptor sterol activation site.

George H Addona1, Heinrich Sandermann, Marek A Kloczewiak, Keith W Miller.   

Abstract

The nicotinic acetylcholine receptor (nAcChoR) has an absolute requirement for cholesterol if agonist-stimulated channel opening is to occur [Biochemistry 25 (1986) 830]. Certain non-polar analogs could replace cholesterol in vectorial vesicle permeability assays. Using a stopped-flow fluorescence assay to avoid the limitations of permeability assays imposed by vesicle morphology, it was shown that polar conjugates of cholesterol could also satisfy the sterol requirement [Biochim. Biophys. Acta 1370 (1998) 299]. Here this assay is used to explore the chemical specificity of sterols. Affinity-purified nAcChoRs from Torpedo were reconstituted into bilayers at mole ratios of 58:12:30 [1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/1,2-dioleoyl-sn-glycero-3-phosphate (DOPA)/steroid]. When the enantiomer of cholesterol was used, or when the stereochemistry at the 3-hydroxy group was changed from beta to alpha by substituting epicholesterol for cholesterol, activation was still supported. The importance of cholesterol's planar ring structure was tested by comparing planar cholestanol (5alpha-cholestan-3beta-ol) with nonplanar coprostanol (5beta-cholestan-3beta-ol). Both supported activation. Thus, these steroids support activation independent of structural features known to be important for modulation of lipid bilayer properties. This provides indirect support for a steroid binding site possessing very lax structural requirements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543379     DOI: 10.1016/s0005-2736(02)00685-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Stereospecific requirement of cholesterol in the function of the serotonin1A receptor.

Authors:  Md Jafurulla; Bhagyashree D Rao; Sugunan Sreedevi; Jean-Marie Ruysschaert; Douglas F Covey; Amitabha Chattopadhyay
Journal:  Biochim Biophys Acta       Date:  2013-09-02

2.  Identification of novel cholesterol-binding regions in Kir2 channels.

Authors:  Avia Rosenhouse-Dantsker; Sergei Noskov; Serdar Durdagi; Diomedes E Logothetis; Irena Levitan
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 3.  Common structural features of cholesterol binding sites in crystallized soluble proteins.

Authors:  Anna N Bukiya; Alejandro M Dopico
Journal:  J Lipid Res       Date:  2017-04-18       Impact factor: 5.922

Review 4.  Challenges and approaches to understand cholesterol-binding impact on membrane protein function: an NMR view.

Authors:  Garima Jaipuria; Tina Ukmar-Godec; Markus Zweckstetter
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

5.  Assessing the lipid requirements of the Torpedo californica nicotinic acetylcholine receptor.

Authors:  Ayman K Hamouda; Mitesh Sanghvi; Daniel Sauls; Tina K Machu; Michael P Blanton
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

Review 6.  Using Sterol Substitution to Probe the Role of Membrane Domains in Membrane Functions.

Authors:  JiHyun Kim; Erwin London
Journal:  Lipids       Date:  2015-03-25       Impact factor: 1.880

Review 7.  The enantiomer of cholesterol.

Authors:  E J Westover; D F Covey
Journal:  J Membr Biol       Date:  2004-11       Impact factor: 1.843

8.  Differential modulation of membrane structure and fluctuations by plant sterols and cholesterol.

Authors:  Aden Hodzic; Michael Rappolt; Heinz Amenitsch; Peter Laggner; Georg Pabst
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

Review 9.  ent-Steroids: novel tools for studies of signaling pathways.

Authors:  Douglas F Covey
Journal:  Steroids       Date:  2008-12-03       Impact factor: 2.668

Review 10.  Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol.

Authors:  Alejandro M Dopico; Anna N Bukiya; Aditya K Singh
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.